Rebecca Taub, SVP, Research & Development at VIA Pharmaceuticals, Inc. (VIAP), bought 157,500 shares at $0.30 ($10K) on 2008-12-05, disclosed to the SEC on 2008-12-19.
Open-market purchase of $10k VIAP by SVP, Research & Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.30 | 32,500 | $10K | 100.0% |
| 2 | $0.00 | 125,000 | $0 | 0.0% |
| Total | $0.06 avg | 157,500 | $10K | 100% |
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |